Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitors
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume -, Issue -, Pages -
Publisher
Future Science Ltd
Online
2020-05-13
DOI
10.4155/fmc-2020-0114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins
- (2020) Karson J. Kump et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors
- (2020) Lulu Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
- (2019) Rumani Singh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Recent advances in the development of Mcl-1 inhibitors for cancer therapy
- (2019) Alexander W. Hird et al. PHARMACOLOGY & THERAPEUTICS
- Why Some Targets Benefit from beyond Rule of Five Drugs
- (2019) Megan Egbert et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations
- (2019) Richard W. Birkinshaw et al. Nature Communications
- Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer
- (2019) Lei Wang et al. Science Advances
- Hot-Spots of Mcl-1 Protein
- (2019) Camille Denis et al. JOURNAL OF MEDICINAL CHEMISTRY
- BCL-2 proteins and apoptosis: Recent insights and unknowns
- (2018) Frank Edlich BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hot-spot analysis for drug discovery targeting protein-protein interactions
- (2018) Mireia Rosell et al. Expert Opinion on Drug Discovery
- Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening
- (2018) Ahmed S. A. Mady et al. Scientific Reports
- Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia
- (2018) Adriana E. Tron et al. Nature Communications
- Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection
- (2017) David A. DeGoey et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
- (2017) Akane Inoue-Yamauchi et al. Nature Communications
- Structural Re-engineering of the α-Helix Mimetic JY-1-106 into Small Molecules: Disruption of the Mcl-1-Bak-BH3 Protein-Protein Interaction with 2,6-Di-Substituted Nicotinates
- (2016) Brandon Drennen et al. ChemMedChem
- Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
- (2016) E. A. Punnoose et al. MOLECULAR CANCER THERAPEUTICS
- Rational Design, Synthesis and Evaluation of Coumarin Derivatives as Protein-protein Interaction Inhibitors
- (2016) Laura De Luca et al. Molecular Informatics
- Modulation of Protein–Protein Interactions for the Development of Novel Therapeutics
- (2016) Ioanna Petta et al. MOLECULAR THERAPY
- Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
- (2016) Duncan E. Scott et al. NATURE REVIEWS DRUG DISCOVERY
- AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein–Protein Interaction Interfaces
- (2015) David Rooklin et al. Journal of Chemical Information and Modeling
- How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets
- (2015) Bradley C. Doak et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Tricyclic Indoles That Potently Inhibit Mcl-1 Using Fragment-Based Methods and Structure-Based Design
- (2015) Jason P. Burke et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity
- (2015) Milan Bruncko et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rational design of protein–protein interaction inhibitors
- (2015) Didier Rognan MedChemComm
- MCL-1 dependency of cisplatin-resistant cancer cells
- (2014) Judith Michels et al. BIOCHEMICAL PHARMACOLOGY
- Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
- (2014) Michelle R. Arkin et al. CHEMISTRY & BIOLOGY
- Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening
- (2014) L-J Liu et al. Cell Death & Disease
- Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity
- (2014) Zhi-Fu Tao et al. ACS Medicinal Chemistry Letters
- Structural Properties of Non-Traditional Drug Targets Present New Challenges for Virtual Screening
- (2013) Ragul Gowthaman et al. Journal of Chemical Information and Modeling
- Analysis of structure-based virtual screening studies and characterization of identified active compounds
- (2012) Peter Ripphausen et al. Future Medicinal Chemistry
- Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design
- (2012) Anders Friberg et al. JOURNAL OF MEDICINAL CHEMISTRY
- Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking
- (2012) Michael M. Mysinger et al. JOURNAL OF MEDICINAL CHEMISTRY
- A natural product-like inhibitor of NEDD8-activating enzyme
- (2011) Chung-Hang Leung et al. CHEMICAL COMMUNICATIONS
- Discovery and Development of Thiazolo[3,2-a]pyrimidinone Derivatives as General Inhibitors of Bcl-2 Family Proteins
- (2011) Bingcheng Zhou et al. ChemMedChem
- Erratum: Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- (2011) Ingrid E. Wertz et al. NATURE
- Inhibition of protein–protein interactions using designed molecules
- (2009) Andrew J. Wilson CHEMICAL SOCIETY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now